Trial Profile
Randomized Comparison of Everolimus- Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery DisEase in Patients With DIABETES Mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms ESSENCE-DM
- 12 Dec 2016 Status changed from active, no longer recruiting to completed.
- 16 Jun 2016 Planned End Date changed from 1 Mar 2016 to 1 Sep 2016.
- 16 Jun 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Sep 2016.